VR Logo

Concord Drugs Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

37 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1995

Chairman: S Nagi Reddy

Managing Director: T Narsimha Reddy

Group: --

Listing: BSE: 538965

Headquarters: Hyderabad, Telangana

Website: www.concorddrugs.in

Key Facts

Market cap: R 11.95 Cr

Revenue (TTM): R 50.98 Cr

Earnings (TTM): R 0.43 Cr

Cash: R 0.18 Cr

Total Debt: R 9.83 Cr

Promoters' ownership: 42.78%

Liquidity: Low

52 Week range: R 12.35 - 23.70

Face value: R10.00

Shares outstanding: 78,61,750

Stock Performance

Time Period Concord Drugs * *
YTD1.33----
1 month16.92----
3 months2.01----
1 Year-31.38----
3 Years-33.61----
5 Years------
10 Years------
As on 21-Jan-2020 *As on
Year Concord Drugs S&P BSE Small Cap S&P BSE Healthcare
2019-33.63-6.85-3.55
2018-29.24-23.41-5.89
2017-34.6959.640.49
2016-19.211.77-12.88